Antioxidative status of patients with alcoholic liver disease in southeastern Taiwan

World Journal of Gastroenterology

Volumn 17, Issue 8, 2011, Pages 1063-1070

  Chen, Ya Ling ^a   Chen, Li Ju ^b   Bair, Ming Jong ^b   Yao, Mei Lan ^b   Peng, Hsiang Chi ^a   Yang, Sien Sing ^c   Yang, Suh Ching ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

^c CATHAY GENERAL HOSPITAL   (Taiwan)

Author keywords

Aborigines; Alcoholic liver disease; Antioxidative status; Cirrhosis; Hepatitis

Indexed keywords

CATALASE; EDETIC ACID; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HEMOGLOBIN; SUPEROXIDE DISMUTASE;

ADULT; ALCOHOL LIVER DISEASE; ARTICLE; BLOOD; CANCER PATIENT; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DIET RESTRICTION; DISEASE SEVERITY; ENZYME ACTIVITY; ERYTHROCYTE; ETHNICITY; FEMALE; GENDER; HEPATITIS; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; MALE; OXIDATION; OXIDATIVE STRESS; TAIWAN; VENOUS BLOOD;

EID: 79955937900     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i8.1063     Document Type: Article

References (50)

1. Hwu HG, Yeh EK, Yeh YL, Chang LY. Alcoholism by Chinese diagnostic interview schedule: a prevalence and validity study. Acta Psychiatr Scand 1988; 77: 7-13
2. Rin H, Lin TY. Mental illness among Formosan aborigines as compared with the Chinese in Taiwan. J Ment Sci 1962; 108: 134-146
3. Shen CY, Lee HS, Huang LC, Tsai KS, Chen DS, Cheng AT. Alcoholism, hepatitis B and C viral infections, and impaired liver function among Taiwanese aboriginal groups. Am J Epidemiol 1996; 143: 936-942
4. Chen DS, Kuo GC, Sung JL, Lai MY, Sheu JC, Chen PJ, Yang PM, Hsu HM, Chang MH, Chen CJ. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: the Taiwan experience. J Infect Dis 1990; 162: 817-822
5. Wu SI, Liu SI, Fang CK, Hsu CC, Sun YW. Prevalence and detection of alcohol use disorders among general hospital inpatients in eastern Taiwan. Gen Hosp Psychiatry 2006; 28: 48-54
6. Cheng AT, Chen WJ. Alcoholism among four aboriginal groups in Taiwan: high prevalences and their implications. Alcohol Clin Exp Res 1995; 19: 81-91
7. Lin HH, Wang LY, Shaw CK, Cheng ML, Chung WK, Chiang HJ, Lin TY, Chen CJ. Combined effects of chronic hepatitis virus infections and substance-use habits on chronic liver diseases in Taiwanese aborigines. J Formos Med Assoc 2002; 101: 826-834
8. Lieber CS. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 2004; 34: 9-19
9. Lieber CS. Metabolism of alcohol. Clin Liver Dis 2005; 9: 1-35
10. Lieber CS. ALCOHOL: its metabolism and interaction with nutrients. Annu Rev Nutr 2000; 20: 395-430
11. Albano E. Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Mol Aspects Med 2008; 29: 9-16
12. Albano E. Alcohol, oxidative stress and free radical damage. Proc Nutr Soc 2006; 65: 278-290
13. Dey A, Cederbaum AI. Alcohol and oxidative liver injury. Hepatology 2006; 43: S63-S74
14. Rouach H, Fataccioli V, Gentil M, French SW, Morimoto M, Nordmann R. Effect of chronic ethanol feeding on lipid peroxidation and protein oxidation in relation to liver pathology. Hepatology 1997; 25: 351-355
15. Peng FC, Tang SH, Huang MC, Chen CC, Kuo TL, Yin SJ. Oxidative status in patients with alcohol dependence: a clinical study in Taiwan. J Toxicol Environ Health A 2005; 68: 1497-1509
16. Donohue TM Jr. Alcohol-induced steatosis in liver cells. World J Gastroenterol 2007; 13: 4974-4978
17. Powell EE, Jonsson JR, Clouston AD. Steatosis: co-factor in other liver diseases. Hepatology 2005; 42: 5-13
18. Diehl AM. Obesity and alcoholic liver disease. Alcohol 2004; 34: 81-87
19. Hill DB, Kugelmas M. Alcoholic liver disease. Treatment strategies for the potentially reversible stages. Postgrad Med 1998; 103: 261-264, 267-268, 273-275
20. Siegmund SV, Brenner DA. Molecular pathogenesis of alcohol-induced hepatic fibrosis. Alcohol Clin Exp Res 2005; 29: 102-109
21. Lalor PF, Faint J, Aarbodem Y, Hubscher SG, Adams DH. The role of cytokines and chemokines in the development of steatohepatitis. Semin Liver Dis 2007; 27: 173-193
22. Wall TL, Thomasson HR, Schuckit MA, Ehlers CL. Subjective feelings of alcohol intoxication in Asians with genetic variations of ALDH2 alleles. Alcohol Clin Exp Res 1992; 16: 991-995
23. Beers RF Jr, Sizer IW. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem 1952; 195: 133-140
24. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969; 27: 502-522
25. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358
26. Cohen JA, Kaplan MM. The SGOT/SGPT ratio--an indicator of alcoholic liver disease. Dig Dis Sci 1979; 24: 835-838
27. Kamimoto Y, Horiuchi S, Tanase S, Morino Y. Plasma clearance of intravenously injected aspartate aminotransferase isozymes: evidence for preferential uptake by sinusoidal liver cells. Hepatology 1985; 5: 367-375
28. Nalpas B, Vassault A, Le Guillou A, Lesgourgues B, Ferry N, Lacour B, Berthelot P. Serum activity of mitochondrial aspartate aminotransferase: a sensitive marker of alcoholism with or without alcoholic hepatitis. Hepatology 1984; 4: 893-896
29. Schisler NJ, Singh SM. Effect of ethanol in vivo on enzymes which detoxify oxygen free radicals. Free Radic Biol Med 1989; 7: 117-123
30. Kleinman WA, Richie JP Jr. Status of glutathione and other thiols and disulfides in human plasma. Biochem Pharmacol 2000; 60: 19-29
31. Ledig M, Doffoel M, Doffoel S, Kopp P, Bockel R, Mandel P. Blood cell superoxide dismutase and enolase activities as markers of alcoholic and nonalcoholic liver diseases. Alcohol 1988; 5: 387-391
32. Rooprai HK, Pratt OE, Shaw GK, Thomson AD. Superoxide dismutase in the erythrocytes of acute alcoholics during detoxification. Alcohol Alcohol 1989; 24: 503-507
33. Fehér J, Lengyel G, Blázovics A. Oxidative stress in the liver and biliary tract diseases. Scand J Gastroenterol Suppl 1998; 228: 38-46
34. Novelli EL, Rodrigues NL, Ribas BO, Novelli Filho JL. Toxicity of chronic ethanol ingestion and superoxide radical formation on seminal vesicle of rats. Food Chem Toxicol 1996; 34: 1003-1007
35. Zhang X, Klein AL, Alberle NS, Norby FL, Ren BH, Duan J, Ren J. Cardiac-specific overexpression of catalase rescues ventricular myocytes from ethanol-induced cardiac contractile defect. J Mol Cell Cardiol 2003; 35: 645-652
36. Lemberg A, Schreier L, Romay S, Fernández MA, Rosello D, Gonzales S, Perazzo JC, Filinger EJ, Tomaro ML. Involvement of serum apolipoprotein AI and B100 and lecithin cholesterol acyl transferase in alcoholic cirrhotics. Ann Hepatol 2007; 6: 227-232
37. Guemouri L, Lecomte E, Herbeth B, Pirollet P, Paille F, Siest G, Artur Y. Blood activities of antioxidant enzymes in alcoholics before and after withdrawal. J Stud Alcohol 1993; 54: 626-629
38. Lecomte E, Herbeth B, Pirollet P, Chancerelle Y, Arnaud J, Musse N, Paille F, Siest G, Artur Y. Effect of alcohol consumption on blood antioxidant nutrients and oxidative stress indicators. Am J Clin Nutr 1994; 60: 255-261
39. Altomare E, Vendemiale G, Albano O. Hepatic glutathione content in patients with alcoholic and non alcoholic liver diseases. Life Sci 1988; 43: 991-998
40. Duce AM, Ortíz P, Cabrero C, Mato JM. S-adenosyl-L-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis. Hepatology 1988; 8: 65-68
41. Ookhtens M, Kaplowitz N. Role of the liver in interorgan homeostasis of glutathione and cyst(e)ine. Semin Liver Dis 1998; 18: 313-329
42. Loguercio C, Taranto D, Vitale LM, Beneduce F, Del Vecchio Blanco C. Effect of liver cirrhosis and age on the glutathione concentration in the plasma, erythrocytes, and gastric mucosa of man. Free Radic Biol Med 1996; 20: 483-488
43. Nanji AA, Zakim D, Rahemtulla A, Daly T, Miao L, Zhao S, Khwaja S, Tahan SR, Dannenberg AJ. Dietary saturated fatty acids down-regulate cyclooxygenase-2 and tumor necrosis factor alfa and reverse fibrosis in alcohol-induced liver disease in the rat. Hepatology 1997; 26: 1538-1545
44. Polavarapu R, Spitz DR, Sim JE, Follansbee MH, Oberley LW, Rahemtulla A, Nanji AA. Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil. Hepatology 1998; 27: 1317-1323
45. Chen HL, Wu MS, Chang WH, Shih SC, Chi H, Bair MJ. Abdominal tuberculosis in southeastern Taiwan: 20 years of experience. J Formos Med Assoc 2009; 108: 195-201
46. Van de Casteele M, Zaman Z, Zeegers M, Servaes R, Fevery J, Nevens F. Blood antioxidant levels in patients with alcoholic liver disease correlate with the degree of liver impairment and are not specific to alcoholic liver injury itself. Aliment Pharmacol Ther 2002; 16: 985-992
47. Devenyi P, Kapur BM, Roy JH. High-density lipoprotein response to alcohol consumption and abstinence as an indicator of liver function in alcoholic patients. Can Med Assoc J 1984; 130: 1445-1447
48. Duhamel G, Forgez P, Nalpas B, Berthelot P, Chapman MJ. Spur cells in patients with alcoholic liver cirrhosis are associated with reduced plasma levels of apoA-II, HDL3, and LDL. J Lipid Res 1983; 24: 1612-1625
49. Lieber CS. Alcohol, protein nutrition, and liver injury. Curr Concepts Nutr 1983; 12: 49-71
50. Fiorelli G, De Feo TM, Duca L, Tavazzi D, Nava I, Fargion S, Cappellini MD. Red blood cell antioxidant and iron status in alcoholic and nonalcoholic cirrhosis. Eur J Clin Invest 2002; 32 Suppl 1: 21-27